| Brown, Conville S |
NCT06087848: A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events |
|
|
| Recruiting | 1/2 | 100 | RoW | Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) | Cellcolabs Clinical LTD. | Cardiovascular Diseases | 10/29 | 10/29 | | |
NCT06074783: A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration |
|
|
| Recruiting | 1/2 | 30 | RoW | Human Allogeneic Bone-Marrow (BM) -Derived Mesenchymal Stromal Cells (MSCs) Product (StromaForte) | Cellcolabs Clinical LTD. | Musculoskeletal Injury | 10/27 | 10/28 | | |
NCT06070532: A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty |
|
|
| Not yet recruiting | 1/2 | 12 | RoW | Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) | Cellcolabs Clinical LTD. | Frailty | 01/26 | 01/27 | | |
NCT05493462: Intranasal Human FGF-1 for Subjects With Parkinson's Disease |
|
|
| Not yet recruiting | 1 | 4 | RoW | Human FGF-1 | Zhittya Genesis Medicine, Inc. | Parkinson Disease | 12/22 | 12/22 | | |
NCT05515419: Allogeneic Cord Blood for Neurological Diseases in Adults |
|
|
| Not yet recruiting | 1 | 80 | NA | Allogeneic cord blood treatment | The Medical Pavilion Bahamas | Neurological Diseases, Stroke, Spinal Cord Injuries | 09/24 | 11/24 | | |
